Keyword: generics


Novartis to Shutter a Sandoz US Plant

09.09.2022 -

In advance of the planned spinoff of generics subsidiary Sandoz into a standalone generics producer, Novartis has announced it is closing one of the subsidiary’s US...


Novartis Definitely Plans to Spin off Sandoz

29.08.2022 -

Novartis has finally confirmed definite plans to spin off its generic drugs arm Sandoz.


FDA Says Pandemic Hasn’t Hit China’s Drug Exports

08.04.2020 - In early March, the Indian government asserted that the coronavirus epidemic in China was affecting its supply of active pharmaceutical ingredients (APIs), on which it relies for...

Chemistry & Life Sciences

DCAT Week 2019

10.01.2019 - Each year in March, the pharmaceutical manufacturing industry gathers in New York City for DCAT Week, and this year is no exception. DCAT Week ’19, the flagship event of the Drug...


FDA Approves Teva’s Generic EpiPen

23.08.2018 - After two years of trying, Israeli generics producer Teva Pharmaceutical Industries has finally gained approval by the US Food and Drug Administration (FDA) for its copy of Mylan’s...


Sanofi Agrees to sell Generics to Advent

12.07.2018 - French drugmaker Sanofi and private equity investor Advent International have agreed a deal under which Advent will acquire Sanofi's European generics business Zentiva for €1.9...


China’s New Drugs Policy Favors Generics

09.04.2018 - The Chinese government has announced a new pharmaceutical policy that will include tax breaks to promote generics, allow compulsory patent licensing during public health...


Loss-making Teva Progresses Turnaround

12.02.2018 - Troubled Israeli generics giant Teva Pharmaceuticals is making "strong progress" on its turnaround plan, despite an even higher loss – approaching $12 billion – in the 2017 fourth...